Pinnacle Associates LTD Novartis Ag Transaction History

Pinnacle Associates LTD

  • $6.3 Billion
  • Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Novartis Ag stock. As of the latest transaction made, Pinnacle Associates LTD holds 61,000 shares of NVS stock, worth $6.04 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
61,000
Previous 58,950 3.48%
Holding current value
$6.04 Million
Previous $6.28 Million 11.81%
% of portfolio
0.11%
Previous 0.1%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
BUY
$106.13 - $120.89 $217,566 - $247,824
2,050 Added 3.48%
61,000 $7.02 Million
Q2 2024

Jul 30, 2024
SELL
$92.57 - $107.37 $105,714 - $122,616
-1,142 Reduced 1.9%
58,950 $6.28 Million
Q1 2024

Apr 26, 2024
SELL
$95.27 - $108.47 $86,505 - $98,490
-908 Reduced 1.49%
60,092 $5.81 Million
Q4 2023

Jan 19, 2024
SELL
$92.27 - $101.54 $20,299 - $22,338
-220 Reduced 0.36%
61,000 $6.16 Million
Q3 2023

Oct 23, 2023
SELL
$94.73 - $105.13 $121,728 - $135,092
-1,285 Reduced 2.06%
61,220 $6.24 Million
Q2 2023

Jul 26, 2023
SELL
$92.52 - $104.91 $117,130 - $132,816
-1,266 Reduced 1.99%
62,505 $6.31 Million
Q1 2023

May 04, 2023
SELL
$80.03 - $92.81 $66,344 - $76,939
-829 Reduced 1.28%
63,771 $5.87 Million
Q4 2022

Jan 31, 2023
SELL
$75.55 - $92.52 $8,159 - $9,992
-108 Reduced 0.17%
64,600 $5.86 Million
Q4 2022

Jan 25, 2023
BUY
$75.55 - $92.52 $48,956 - $59,952
648 Added 1.01%
64,708 $0
Q3 2022

Oct 31, 2022
SELL
$74.61 - $87.26 $124,225 - $145,287
-1,665 Reduced 2.53%
64,060 $4.87 Million
Q2 2022

Aug 02, 2022
SELL
$80.52 - $93.75 $46,943 - $54,656
-583 Reduced 0.88%
65,725 $5.56 Million
Q1 2022

May 05, 2022
SELL
$80.11 - $90.62 $21,870 - $24,739
-273 Reduced 0.41%
66,308 $5.82 Million
Q4 2021

Feb 02, 2022
SELL
$79.7 - $88.13 $572,166 - $632,685
-7,179 Reduced 9.73%
66,581 $5.82 Million
Q3 2021

Oct 19, 2021
SELL
$81.78 - $95.14 $101,816 - $118,449
-1,245 Reduced 1.66%
73,760 $6.03 Million
Q2 2021

Aug 02, 2021
SELL
$85.24 - $94.15 $61,798 - $68,258
-725 Reduced 0.96%
75,005 $6.84 Million
Q1 2021

May 12, 2021
SELL
$83.5 - $98.47 $131,262 - $154,794
-1,572 Reduced 2.03%
75,730 $6.47 Million
Q4 2020

Jan 26, 2021
BUY
$78.07 - $94.43 $11,554 - $13,975
148 Added 0.19%
77,302 $7.3 Million
Q3 2020

Oct 23, 2020
BUY
$82.14 - $91.0 $48,380 - $53,599
589 Added 0.77%
77,154 $6.71 Million
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $99,462 - $111,961
-1,229 Reduced 1.58%
76,565 $6.69 Million
Q1 2020

May 13, 2020
SELL
$70.67 - $99.01 $27,631 - $38,712
-391 Reduced 0.5%
77,794 $6.41 Million
Q4 2019

Feb 03, 2020
BUY
$84.35 - $95.37 $35,764 - $40,436
424 Added 0.55%
78,185 $7.4 Million
Q3 2019

Nov 08, 2019
BUY
$85.54 - $94.26 $20,187 - $22,245
236 Added 0.3%
77,761 $6.76 Million
Q2 2019

Aug 05, 2019
BUY
$75.4 - $92.8 $17,719 - $21,808
235 Added 0.3%
77,525 $7.08 Million
Q1 2019

May 10, 2019
SELL
$75.32 - $86.15 $262,565 - $300,318
-3,486 Reduced 4.32%
77,290 $7.43 Million
Q4 2018

Feb 05, 2019
SELL
$73.66 - $82.02 $59,517 - $66,272
-808 Reduced 0.99%
80,776 $6.93 Million
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $17,672 - $20,441
-264 Reduced 0.32%
81,584 $7.03 Million
Q2 2018

Aug 08, 2018
SELL
$64.91 - $73.36 $1.12 Million - $1.26 Million
-17,216 Reduced 17.38%
81,848 $6.18 Million
Q1 2018

May 11, 2018
SELL
$70.39 - $84.15 $315,206 - $376,823
-4,478 Reduced 4.32%
99,064 $8.01 Million
Q4 2017

Feb 12, 2018
SELL
$72.33 - $77.64 $129,181 - $138,665
-1,786 Reduced 1.7%
103,542 $8.69 Million
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $306,049 - $318,970
4,128 Added 4.08%
105,328 $9.04 Million
Q2 2017

Aug 09, 2017
BUY
N/A
101,200
101,200 $8.45 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Pinnacle Associates LTD Portfolio

Follow Pinnacle Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email